Synthetic Conjugated Estrogens, B

Synthetic conjugated estrogens B is a mixture of nine synthetic estrogenic substances including sodium estrone sulfate and sodium equilin sulfate analogs, used for the treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause. Like other conjugated estrogens, the individual components are hydrolyzed to active unconjugated estrogens that bind to estrogen receptors in hypothalamic thermoregulatory centers, relieving vasomotor instability. It differs from conjugated equine estrogens in its fully synthetic composition.

Yes, Synthetic Conjugated Estrogens, B is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.